← Leaderboards
Shannon L. Gillespie
Ohio State University
$2,647,931
Attributed
$3,812,018
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,812,018 · 4
By mechanism
R01$3,249,135 · 2
K23$476,982 · 1
F31$85,901 · 1
Top collaborators
- Seuli Moushumi Bose Brill3 shared
Most similar at Ohio State University
Same institution · by research overlap
- Claire F Verschraegen$7,194,564
- David P Carbone$20,647,321
- William E. Carson$27,905,247
- David Michael O'Malley$1,562,108
- Caroline C Whitacre$5,769,902
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneDesignPregnancyBirthPremature BirthSamplingLinkPrenatalPreventMediatingCytokineRecording Of Previous EventsCohortInnovationInflammatoryWomanCessation Of LifeBiologicalPlasmaInfantPlayLifeInterleukinsMentors
Grant awards (12)
Evaluating a multi-modal maternal infant perinatal outpatient delivery system: A randomized controlled trial (MOMI PODS RCT)$765,106
R01 · FY2025 · NR · contact PI
Prenatal Immunomonitoring in Spontaneous Preterm Birth Prevention (PROMIS)$477,077
R01 · FY2025 · HD · contact PI
Evaluating a multi-modal maternal infant perinatal outpatient delivery system: A randomized controlled trial (MOMI PODS RCT)$776,064
R01 · FY2024 · NR · contact PI
Prenatal Immunomonitoring in Spontaneous Preterm Birth Prevention (PROMIS)$443,883
R01 · FY2024 · HD · contact PI
Evaluating a multi-modal maternal infant perinatal outpatient delivery system: A randomized controlled trial (MOMI PODS RCT)$787,005
R01 · FY2023 · NR · contact PI
Maternal Immune Responsiveness As CLinical Target for Preterm Birth Prevention (MIRACL)$140,792
K23 · FY2020 · NR · contact PI
Maternal Immune Responsiveness As CLinical Target for Preterm Birth Prevention (MIRACL)$53,986
K23 · FY2020 · NR · contact PI
Maternal Immune Responsiveness As CLinical Target for Preterm Birth Prevention (MIRACL)$140,999
K23 · FY2019 · NR · contact PI
Maternal Immune Responsiveness As CLinical Target for Preterm Birth Prevention (MIRACL)$141,205
K23 · FY2018 · NR · contact PI
Pathways to shortened gestation among Black women$13,681
F31 · FY2015 · NR · contact PI
Pathways to shortened gestation among Black women$36,332
F31 · FY2014 · NR · contact PI
Pathways to shortened gestation among Black women$35,888
F31 · FY2013 · NR · contact PI